Therapeutics News
-
Japanese firm Eisai partners with Washington University for treatment of neuro diseases
Therapeutics | News | 0 Comment | 19 Dec, 2022
Eisai and Washington University School of Medicine in St. Louis have entered into a comprehensive research collaboration...Read more
-
Trial of ultrasound treatment for Alzheimer’s underway in Australia
Therapeutics | News | 0 Comment | 13 Dec, 2022
A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...Read more
-
Singapore identifies gene that controls scarring in damaged hearts
Therapeutics | News | 0 Comment | 12 Dec, 2022
Scientists at Duke-NUS Medical School in Singapore have identified a gene that controls the behaviour of a specific type...Read more
-
Hong Kong develops multifunctional nanoparticle for diagnosis & treatment of glioma
Therapeutics | News | 0 Comment | 28 Nov, 2022
A Hong Kong Baptist University (HKBU) collaborative research team, along with researchers at Hong Kong Polytechnic ...Read more
-
Integrated stem cell solutions to combat rising degenerative diseases amongst Malaysians
Therapeutics | News | 0 Comment | 25 Nov, 2022
According to the Department of Statistics Malaysia (DOSM), population with age 60 and above is increasing yearly and Mal...Read more
-
Korea inks MoU with US to establish precision medicine research platform
Therapeutics | News | 0 Comment | 17 Nov, 2022
Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...Read more
-
GSK invests S$44 M in manufacturing facility at Singapore for cancer treatment
Therapeutics | Company results | By Hithaishi C Bhaskar | 9 Comment | 17 Nov, 2022
The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New P...Read more
-
Australia announces world first regulatory approval for donor derived microbiome drug
Therapeutics | News | 0 Comment | 09 Nov, 2022
Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...Read more
-
NZ-based startup develops eye drops to treat keratoconus
Therapeutics | News | 0 Comment | 08 Nov, 2022
A new University of Auckland spin-out company, TheiaNova, is working to introduce a groundbreaking, non-invasive treatme...Read more
-
I Peace partners with the California Institute for Regenerative Medicine
Therapeutics | News | 0 Comment | 03 Nov, 2022
Founded in 2015 by Koji Tanabe, a graduate of Professor Shinya Yamanaka's laboratory at Kyoto Univer...Read more
-
Australia announces world-first brain cancer clinical trials
Therapeutics | News | 0 Comment | 01 Nov, 2022
A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...Read more
-
Therapeutics | Opinion | By Hithaishi C Bhaskar | 2 Comment | 01 Nov, 2022
How would you describe your primary mission and vision of the Centre for Microbiome Medicine? Microbiome is the l...Read more
-
JW Therapeutics accelerates R&D of T cell-based immunotherapies in China
Therapeutics | News | 0 Comment | 27 Oct, 2022
JW Therapeutics and 2seventy bio have announced a strategic alliance to establish a translational and clinical cell ther...Read more
-
NZ brain scientist wins research medal
Therapeutics | News | 0 Comment | 21 Oct, 2022
The winner of this year's pre-eminent research award in the Faculty of Medical and Health Sciences, Professor Michael (M...Read more
-
Singapore manipulates stress response in cells to help slow down ageing
Therapeutics | News | 0 Comment | 20 Oct, 2022
Nanyang Technological University (NTU) Singapore scientists have found that a stress response in cells, when ‘swit...Read more
-
Etana unveils biopharmaceutical factory in Indonesia
Therapeutics | News | 0 Comment | 20 Oct, 2022
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...Read more
-
Korea's LG Chem to acquire AVEO Oncology for $566 M
Therapeutics | News | 0 Comment | 20 Oct, 2022
South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...Read more
-
Singapore identifies new cell population in Alzheimer's disease
Therapeutics | News | 0 Comment | 17 Oct, 2022
An immunity research study has found that the previously identified disease-associated microglia (DAM) population d...Read more
